0001209191-23-037192.txt : 20230614
0001209191-23-037192.hdr.sgml : 20230614
20230614190237
ACCESSION NUMBER: 0001209191-23-037192
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230613
FILED AS OF DATE: 20230614
DATE AS OF CHANGE: 20230614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Karen L.
CENTRAL INDEX KEY: 0001639637
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40384
FILM NUMBER: 231015604
MAIL ADDRESS:
STREET 1: C/O JAZZ PHARMACEUTICALS PLC
STREET 2: 5TH FL, WATERLOO EXCHANGE, WATERLOO RD
CITY: DUBLIN L2 4
STATE: L2
ZIP: 0
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Talaris Therapeutics, Inc.
CENTRAL INDEX KEY: 0001827506
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 570 PRESTON ST.
STREET 2: SUITE 400
CITY: LOUISVILLE
STATE: KY
ZIP: 40202
BUSINESS PHONE: 502-398-9250
MAIL ADDRESS:
STREET 1: 93 WORCESTER STREET
CITY: WELLESLEY
STATE: MA
ZIP: 02481
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-13
0
0001827506
Talaris Therapeutics, Inc.
TALS
0001639637
Smith Karen L.
C/O TALARIS THERAPEUTICS, INC.
93 WORCESTER ST.
WELLESLEY
MA
02481
1
0
0
0
0
Stock Option (Right to Buy)
2.54
2023-06-13
4
A
0
20500
0.00
A
2033-06-13
Common Stock
20500
20500
D
The shares underlying this option shall vest as follows: the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting.
/s/ Mary Kay Fenton, attorney-in-fact
2023-06-14